Park Tyler, Huber Timothy, Marchak Katherine, Hart James, Walker Lisa
University of Colorado, Anschutz School of Medicine, Aurora, Colorado.
Jefferson Radiology, Interventional Radiology, East Hartford, Connecticut.
Semin Intervent Radiol. 2024 Aug 19;41(3):293-301. doi: 10.1055/s-0044-1788339. eCollection 2024 Jun.
Thyroid radiofrequency ablation (RFA) is a minimally invasive procedure that can be used to treat patients with benign thyroid nodules and is a good alternative to thyroidectomy or radioactive iodine. Thyroid RFA is commonly performed with local lidocaine or minimal/moderate sedation and has a minimal risk profile and few side effects. The efficacy of thyroid RFA has been well documented in the literature, with a volume reduction rate of 67 to 75% at 1 year. Another emerging technique for nodule size reduction is thyroid artery embolization which is a minimally invasive procedure that may be performed in patients with nodular goiters, particularly with substernal thyroid nodule extension, and who are either poor surgical candidates or do not want surgery. This article reviews thyroid RFA, focusing on the relevant preprocedural, procedural, and postprocedural imaging, as well as a discussion on the emerging role of thyroid artery embolization.
甲状腺射频消融术(RFA)是一种微创手术,可用于治疗良性甲状腺结节患者,是甲状腺切除术或放射性碘治疗的良好替代方案。甲状腺RFA通常在局部利多卡因或轻度/中度镇静下进行,风险极小,副作用也很少。甲状腺RFA的疗效在文献中有充分记载,1年时体积缩小率为67%至75%。另一种用于减小结节大小的新兴技术是甲状腺动脉栓塞术,这是一种微创手术,可用于结节性甲状腺肿患者,特别是伴有胸骨后甲状腺结节延伸的患者,以及手术风险高或不愿接受手术的患者。本文综述了甲状腺RFA,重点介绍了相关的术前、术中和术后影像学检查,以及对甲状腺动脉栓塞术新兴作用的讨论。